Skip to content

A Multicenter randomized controlled study of the Clinical Effect Comparison of Phacoemulsification Combined with Goniosynechialysis and Combined with Goniosynechialysis plus Goniotomy for Advanced Primary Angle-Closure Glaucoma

A Multicenter randomized controlled study of the Clinical Effect Comparison of Phacoemulsification Combined with Goniosynechialysis and Combined with Goniosynechialysis plus Goniotomy for Advanced Primary Angle-Closure Glaucoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104614
Enrollment
Unknown
Registered
2025-06-19
Start date
2024-10-10
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Angle-Closure Glaucoma

Interventions

Control group:Phacoemulsification cataract extraction combined with intraocular lens implantation plus 360° goniosynechialysis.
Experimental group B:Phacoemulsification cataract extraction combined with intraocular lens implantation plus 360° goniosynechialysis and 120° goniotomy.
Experimental group C:Phacoemulsification cataract extraction combined with intraocular lens implantation plus 120° goniosynechialysis and 120° goniotomy.

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 79 Years

Inclusion criteria

Inclusion criteria: Patients with intermediate and advanced primary angle-closure glaucoma complicated with cataracts. 1. Age 45-79 years old, gender is not limited; 2. Meet the diagnostic criteria for intermediate and advanced PACG; 3. Those who have obvious cataract and corrected visual acuity <=0.5 (standard logarithmic visual acuity chart), or who need to undergo lens extraction as assessed by a clinician; 4. Intraocular pressure is difficult to control with drugs, and the disease continues to progress; 5. Informed consent of the patient, agreeing to cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Previous history of intraocular surgery or ocular trauma (except laser iridotomy or laser iridoplasty); 2. Combined with other types of glaucoma, such as primary open-angle glaucoma, various types of secondary glaucoma (secondary angle-closure glaucoma, corticosteroid glaucoma, secondary glaucoma with angle regression, neovascular glaucoma, glaucoma secondary to inflammation, true microphthalmia and pseudoexfoliation syndrome, etc.); 3. Acute exacerbation of acute primary angle-closure glaucoma with uncontrolled inflammation; 4. Long-term use of topical or systemic glucocorticoids or combined with severe systemic diseases; 5. Patients with poor corneal condition, severe senile ring and gonioscopy before surgery who cannot see the structure of the angle; 6. Corrected visual acuity of the contralateral eye of the test eye is less than 0.05 (< 0.05).

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;Types of anti glaucoma drugs;

Secondary

MeasureTime frame
Cup to disk ratio;Retinal nerve fiber layer thickness;Mean defect;Peripheral anterior synechiae;Central anterior chamber depth;Best corrected visual acuity;Visual acuity;

Countries

China

Contacts

Public ContactQiao Chunyan

Beijing Tongren Hospital

chunyan_qiao@163.com+86 176 1067 8637

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026